Bruni J V & Co. Co. Has $37.15 Million Stock Holdings in The Cigna Group (NYSE:CI)

Bruni J V & Co. Co. decreased its stake in shares of The Cigna Group (NYSE:CIFree Report) by 0.9% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 107,239 shares of the health services provider’s stock after selling 987 shares during the quarter. The Cigna Group accounts for about 4.1% of Bruni J V & Co. Co.’s holdings, making the stock its 9th biggest holding. Bruni J V & Co. Co.’s holdings in The Cigna Group were worth $37,152,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Meeder Asset Management Inc. grew its position in shares of The Cigna Group by 353.5% in the 3rd quarter. Meeder Asset Management Inc. now owns 11,800 shares of the health services provider’s stock worth $4,088,000 after acquiring an additional 9,198 shares in the last quarter. OneAscent Financial Services LLC bought a new position in The Cigna Group during the third quarter worth $454,000. OneAscent Wealth Management LLC acquired a new position in The Cigna Group in the third quarter worth $358,000. AMG National Trust Bank increased its stake in The Cigna Group by 5.7% during the third quarter. AMG National Trust Bank now owns 4,072 shares of the health services provider’s stock valued at $1,411,000 after purchasing an additional 218 shares during the last quarter. Finally, Aljian Capital Management LLC acquired a new stake in shares of The Cigna Group during the third quarter worth $324,000. 86.99% of the stock is currently owned by institutional investors and hedge funds.

The Cigna Group Stock Performance

Shares of CI opened at $322.40 on Tuesday. The company has a 50-day moving average of $338.17 and a two-hundred day moving average of $339.27. The stock has a market cap of $89.68 billion, a price-to-earnings ratio of 30.42, a PEG ratio of 0.97 and a beta of 0.51. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.72 and a quick ratio of 0.72. The Cigna Group has a one year low of $253.95 and a one year high of $370.83.

The Cigna Group (NYSE:CIGet Free Report) last announced its earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.22 by $0.29. The company had revenue of $63.70 billion for the quarter, compared to the consensus estimate of $59.58 billion. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The company’s revenue was up 29.8% on a year-over-year basis. During the same period in the previous year, the business earned $6.77 EPS. On average, equities research analysts expect that The Cigna Group will post 28.5 earnings per share for the current year.

The Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 19th. Shareholders of record on Wednesday, December 4th will be given a dividend of $1.40 per share. The ex-dividend date is Wednesday, December 4th. This represents a $5.60 dividend on an annualized basis and a yield of 1.74%. The Cigna Group’s payout ratio is presently 52.83%.

Wall Street Analysts Forecast Growth

CI has been the topic of several research reports. Jefferies Financial Group increased their price objective on shares of The Cigna Group from $402.00 to $422.00 and gave the stock a “buy” rating in a research note on Tuesday, September 17th. Stephens restated an “overweight” rating and issued a $410.00 price target on shares of The Cigna Group in a research note on Friday, November 1st. StockNews.com downgraded The Cigna Group from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Barclays lifted their target price on The Cigna Group from $405.00 to $420.00 and gave the company an “overweight” rating in a research note on Tuesday, November 5th. Finally, Deutsche Bank Aktiengesellschaft decreased their price target on The Cigna Group from $398.00 to $394.00 and set a “buy” rating for the company in a research note on Monday, November 4th. One equities research analyst has rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, The Cigna Group presently has an average rating of “Buy” and a consensus target price of $394.64.

Get Our Latest Research Report on CI

The Cigna Group Profile

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Featured Articles

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for The Cigna Group (NYSE:CI)

Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.